Connie Montgomery: Every Patient Deserves Representation in Clinical Research
Connie Montgomery, National Member Board of Trustees Camden Coalition at Camden Coalition, shared American Society of Hematology‘s a post on LinkedIn:
“Trialport supports that all people need to be represented in clinical trials especially for those of us living with bleeding disorders and other diseases.”
American Society of Hematology shared a post on LinkedIn:
“Representation in clinical trials doesn’t improve by accident—it improves by design.
The ASH Toolkit for Clinical Trial Sponsors provides a step-by-step, practical resource to build equity into the trial life cycle from the outset.
Find concrete recommendations, examples, and curated references to help enhance access, broaden participation, and generate results that truly reflect the patients impacted by the disease or therapy.
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 30, 2026, 04:12Maia Meier: Driving Change for Women and Girls with Bleeding Disorders
-
Jun 30, 2026, 03:19Wolfgang Miesbach: Weight-Bearing Lunge Test for Ankle Assessment in Haemophilia?
-
Jun 30, 2026, 03:06Salvatore Brugaletta: Is Twelve Months of DAPT Still Too Long After ACS?
-
Jun 30, 2026, 02:55Edward Lee Carter: How A Landmark Stewardship Shift Reduced Unnecessary Antiplatelet Use Across VISN 8
-
Jun 30, 2026, 02:43Nicolas Gendron: More than a Research Fellowship – Leaving the Wagner Lab
-
Jun 30, 2026, 02:29Wolfgang Miesbach: Can We ‘Pre‑Tame’ the Immune System to Unlock Better AAV8 FVIII Expression?
-
Jun 30, 2026, 02:21Mohammad Khalil: Evaluating DAPT Duration after Percutaneous Coronary Intervention
-
Jun 30, 2026, 02:11Rishdha Roshad: Activated Clotting Time – Adult vs Pediatric
-
Jun 30, 2026, 02:02Julia Castillo González: Role of Cortistatin During the Acute and Subacute Phases of Ischemic Stroke